Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | JAK1 | P23458 | 1/20 | 0.40 |
| ▸ | XDH | P47989 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29992520 | 1.00 | SCN9A (0.41) | SCN9AJAK2JAK1XDH | |
| SCHEMBL27167502 | 0.86 | — | — | |
| SCHEMBL29898225 | 0.86 | — | — | |
| SCHEMBL1646923 | 0.84 | SCN9A (0.43) | SCN9A | |
| SCHEMBL26619562 | 0.83 | SCN9A (0.42) | SCN9AXDH | |
| SCHEMBL29898261 | 0.82 | PFKFB2 (0.41) | SCN9AXDH | |
| SCHEMBL27167474 | 0.82 | PFKFB2 (0.41) | SCN9AXDH | |
| SCHEMBL1647146 | 0.81 | XDH (0.42) | SCN9AXDH | |
| SCHEMBL1647841 | 0.81 | XDH (0.44) | XDH | |
| SCHEMBL1647669 | 0.78 | SCN9A (0.40) | SCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115160299-B | Xanthine oxidase inhibitor | 江苏新元素医药科技有限公司 | 2024-08-16 | — | — | CN | disclosed |
| US-20240262808-A1 | XANTHINE OXIDASE INHIBITOR | JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2024-08-08 | — | — | US | disclosed |
| EP-4335844-A1 | CLASS OF XANTHINE OXIDASE INHIBITORS | Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd. (CN) | 2024-03-13 | — | — | EP | disclosed |
| CN-115160299-A | Xanthine oxidase inhibitor | 江苏新元素医药科技有限公司 | 2022-10-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262808-A1 | XANTHINE OXIDASE INHIBITOR | XDH, PNPO, MPO | SCN9A 896/4885JAK2 1097/4885JAK1 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.